btmfdr2 Monday, May 06, 2013 12:26:24 PM
Re: 10 bagger post# 8288 Post # of 8891
CPHMF - I bought more this morning. I paused after buying my initially figuring I'd wait for a pullback which never came.
According to the CC the Isotrenton market in the U.S. has grown to $800MM of which Absorbica is at 7.5% market share right now after five months on the market. I think peak sales of Absorbica could be much higher than the $200MM figure in Jason Napadono's March Zachs report. Being the only promoted Isotrenton in the US, and having the dosing flexibility, I don't see why this shouldn't become bigger than Clarivis which is a $350MM product.
A double this year should be easy. This is easy money.
Recent CPH News
- Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call • PR Newswire (Canada) • 05/03/2024 11:05:00 AM
- Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results • PR Newswire (Canada) • 03/14/2024 09:00:00 PM
- Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call • PR Newswire (Canada) • 03/08/2024 12:00:00 PM
- Will Uplisting Be the Catalyst to Send Shares of this Pharma Company Higher? • AllPennyStocks.com • 01/29/2024 05:56:00 PM
- Will Uplisting Be the Catalyst to Send Sharesof this Pharma Company Higher? • AllPennyStocks.com • 01/29/2024 05:56:00 PM
- Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading • PR Newswire (Canada) • 01/29/2024 12:15:00 PM
- Cipher Pharmaceuticals Announces Change of Auditor • PR Newswire (Canada) • 11/24/2023 10:00:00 PM
- Cipher Pharmaceuticals Announces Normal Course Issuer Bid • PR Newswire (Canada) • 11/15/2023 10:00:00 PM
- Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023 • PR Newswire (Canada) • 11/09/2023 10:00:00 PM
- Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference Call • PR Newswire (Canada) • 10/27/2023 11:00:00 AM
- Cipher Pharmaceuticals Announces Final Results of Substantial Issuer Bid • PR Newswire (Canada) • 10/12/2023 01:57:00 PM
- Cipher Pharmaceuticals Provides Reminder of the Upcoming Expiration of its Substantial Issuer Bid • PR Newswire (Canada) • 10/03/2023 11:00:00 AM
- Cipher Pharmaceuticals Announces Intention to Commence Substantial Issuer Bid, Aggregate Price up to $6 Million Canadian Dollars • PR Newswire (Canada) • 09/05/2023 11:00:00 AM
- Cipher Pharmaceuticals Releases Q2 2023 Results, Announces Launch of Epuris in Mexico • PR Newswire (Canada) • 08/10/2023 09:00:00 PM
- Cipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference Call • PR Newswire (Canada) • 07/28/2023 11:00:00 AM
- Cipher Partner, Moberg Pharma Announces Approval for MOB-015 in the European Union • PR Newswire (Canada) • 07/05/2023 11:00:00 AM
- Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders • PR Newswire (Canada) • 06/21/2023 04:53:00 PM
- Cipher Pharmaceuticals Reports First Quarter Results, Highlighted by Record Cash Per Share and Strong Financial Flexibility • PR Newswire (Canada) • 05/11/2023 09:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM